Voyager Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Voyager Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Voyager Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 8.33 %, a 74.1% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Return On Equity for 2023 was 63.9 %.
  • Voyager Therapeutics, Inc. annual Return On Equity for 2022 was -67.6 %, a 1.81% decline from 2021.
  • Voyager Therapeutics, Inc. annual Return On Equity for 2021 was -66.4 %, a 315% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 63.9 +131 Jan 1, 2023 Dec 31, 2023
2022 -67.6 -1.2 -1.81% Jan 1, 2022 Dec 31, 2022
2021 -66.4 -97.2 -315% Jan 1, 2021 Dec 31, 2021
2020 30.8 +71.7 Jan 1, 2020 Dec 31, 2020
2019 -40.9 +80 +66.2% Jan 1, 2019 Dec 31, 2019
2018 -121 -57.6 -91.1% Jan 1, 2018 Dec 31, 2018
2017 -63.2 -36.6 -138% Jan 1, 2017 Dec 31, 2017
2016 -26.6 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.